Literature DB >> 7359146

Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.

L Stendahl-Brodin, H Link.   

Abstract

The prognosis in multiple sclerosis (MS) is related to the presence of an abnorma humoral immune response within the central nervous system: 14/17 MS patients (82%) without oligoclonal CSF IgG displayed no or slight disability after a mean duration of MS of 17 years, while 53% of 88 patients with oligoclonal CSF IgG had a benign course after a mean duration of 13 years (p less than 0.05). A benign course also was more often accompanied by a normal CSF IgG index. MS patients without oligoclonal CSF IgG had elevated CSF/serum ratios of albumin in 6%, and of the complement factors C3 in 0% and C4 in 6%, as against 20%, 27% and 37%, respectively, in MS patients with oligoclonal CSF IgG.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7359146      PMCID: PMC490482          DOI: 10.1136/jnnp.43.2.102

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

Review 1.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

2.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

3.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

Authors:  H Link; G Tibbling
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

4.  Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions.

Authors:  J E Olsson; H Link
Journal:  Arch Neurol       Date:  1973-06

5.  Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis.

Authors:  H Link
Journal:  Clin Chim Acta       Date:  1973-07-27       Impact factor: 3.786

6.  Individual cerebrospinal fluid (CSF) proteins in the evaluation of increased CSF total protein.

Authors:  H Link; O Zettervall; G Blennow
Journal:  Z Neurol       Date:  1972

7.  Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system.

Authors:  E C Laterre; A Callewaert; J F Heremans; Z Sfaello
Journal:  Neurology       Date:  1970-10       Impact factor: 9.910

8.  Immunoglobulins in multiple sclerosis and infections of the nervous system.

Authors:  H Link; R Müller
Journal:  Arch Neurol       Date:  1971-10

9.  Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: disability, duration and age of onset.

Authors:  J E Olsson; H Link; R Müller
Journal:  J Neurol Sci       Date:  1976-02       Impact factor: 3.181

10.  Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. A simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands.

Authors:  K P Johnson; S C Arrigo; B J Nelson; A Ginsberg
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

View more
  18 in total

1.  Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.

Authors:  Xiaoli Yu; Mark Burgoon; Miyoko Green; Olga Barmina; Kathryn Dennison; Tiffany Pointon; Molly Davis; Don Gilden
Journal:  J Neuroimmunol       Date:  2011-11-12       Impact factor: 3.478

2.  Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.

Authors:  Sophie Desplat-Jégo; Lionel Feuillet; Jean Pelletier; Dominique Bernard; André Ali Chérif; José Boucraut
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

Review 3.  Diagnosis of multiple sclerosis.

Authors:  W I McDonald
Journal:  BMJ       Date:  1989-09-09

4.  Evaluation by MRI of paraparesis and tetraparesis of undiagnosed aetiology.

Authors:  E B Ringelstein; D Krieger; B Hünermann
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

5.  Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.

Authors:  Christiane Gasperi; Anke Salmen; Gisela Antony; Antonios Bayas; Christoph Heesen; Tania Kümpfel; Ralf A Linker; Friedemann Paul; Martin Stangel; Björn Tackenberg; Florian Then Bergh; Clemens Warnke; Frank Weber; Heinz Wiendl; Brigitte Wildemann; Uwe K Zettl; Ulf Ziemann; Frauke Zipp; Hayrettin Tumani; Ralf Gold; Bernhard Hemmer
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

Review 6.  Cerebrospinal fluid.

Authors:  E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

7.  A study of oligoclonal band negative multiple sclerosis.

Authors:  A Z Zeman; D Kidd; B N McLean; M A Kelly; D A Francis; D H Miller; B E Kendall; P Rudge; E J Thompson; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

8.  Suspected and clinically definite multiple sclerosis: the relationship between CSF immunoglobulins and clinical course.

Authors:  A J Thompson; M Hutchinson; E A Martin; M Mansfield; A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

9.  Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.

Authors:  Dorothea Buck; Eva Albrecht; Muhammad Aslam; An Goris; Natalie Hauenstein; Angela Jochim; Sabine Cepok; Verena Grummel; Bénédicte Dubois; Achim Berthele; Peter Lichtner; Christian Gieger; Juliane Winkelmann; Bernhard Hemmer
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

10.  Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

Authors:  R W Walker; E J Thompson; W I McDonald
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.